Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that David B. Weiner, Ph.D., Professor, Department of Pathology & Laboratory Medicine, University of Pennsylvania School of Medicine, and chairman of Inovio's scientific advisory board, will make a presentation at Novel Vaccines: Design & Development, part of the ImVacs Immunotherapeutics & Vaccine Summit being hosted August 18th - 19th at the Renaissance Providence Hotel in Providence, RI. Dr. Weiner will make his presentation, entitled, "Development of Novel DNA Vaccines for Influenza and HIV," on Wednesday, August 19, 2009, at 1:45 p.m.
